Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Ser18-Ser210
Accession # Q9UNN8
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human EPCR Antibody
Detection of Human EPCR by Western Blot.
Western blot shows lysates of human skin tissue, human placenta tissue, and HUVEC human umbilical vein endothelial cells. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Human EPCR Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2245) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for EPCR at approximately 40-45 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
EPCR in Human Liver.
EPCR was detected in immersion fixed paraffin-embedded sections of human liver using 1.7 µg/mL Goat Anti-Human EPCR Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2245) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Detection of EPCR by Immunocytochemistry/ Immunofluorescence
Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of EPCR by Western Blot
Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of EPCR by Western Blot
Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of EPCR by Immunocytochemistry/ Immunofluorescence
Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human EPCR Antibody
CyTOF-ready
Flow Cytometry
Sample: HUVEC human umbilical vein endothelial cells
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human liver
Western Blot
Sample: Human skin tissue, human placenta tissue, and HUVEC human umbilical vein endothelial cells
Flow Cytometry Panel Builder
Bio-Techne Knows Flow Cytometry
Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.
Advanced Features
- Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
- Spillover Popups - Visualize the spectra of individual fluorochromes
- Antigen Density Selector - Match fluorochrome brightness with antigen density
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: EPCR
Long Name
Alternate Names
Gene Symbol
UniProt
Additional EPCR Products
Product Documents for Human EPCR Antibody
Product Specific Notices for Human EPCR Antibody
For research use only
Related Research Areas
Citations for Human EPCR Antibody
Customer Reviews for Human EPCR Antibody
There are currently no reviews for this product. Be the first to review Human EPCR Antibody and earn rewards!
Have you used Human EPCR Antibody?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- 7-Amino Actinomycin D (7-AAD) Cell Viability Flow Cytometry Protocol
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- Detection & Visualization of Antibody Binding
- Extracellular Membrane Flow Cytometry Protocol
- Flow Cytometry Protocol for Cell Surface Markers
- Flow Cytometry Protocol for Staining Membrane Associated Proteins
- Flow Cytometry Staining Protocols
- Flow Cytometry Troubleshooting Guide
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Intracellular Flow Cytometry Protocol Using Alcohol (Methanol)
- Intracellular Flow Cytometry Protocol Using Detergents
- Intracellular Nuclear Staining Flow Cytometry Protocol Using Detergents
- Intracellular Staining Flow Cytometry Protocol Using Alcohol Permeabilization
- Intracellular Staining Flow Cytometry Protocol Using Detergents to Permeabilize Cells
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Propidium Iodide Cell Viability Flow Cytometry Protocol
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Characterization of Human Th22 Cells
- Protocol for the Characterization of Human Th9 Cells
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- Protocol: Annexin V and PI Staining by Flow Cytometry
- Protocol: Annexin V and PI Staining for Apoptosis by Flow Cytometry
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Fluorokine Flow Cytometry Kits
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars